Position in CYTK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$7,541,103
+$5,264,770 QoQ
Shares Held
88,521
+156.3% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#138
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names. CYTK ranks #24 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,541,103 | 88,521 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,276,333 | 34,537 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,986,054 | 62,733 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,246,377 | 59,068 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $973,589 | 29,467 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $977,460 | 24,321 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,244,443 | 26,455 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,745,937 | 33,067 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,659,316 | 30,626 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,717,624 | 24,499 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,733,001 | 20,757 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $823,613 | 27,957 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $682,214 | 20,914 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $751,095 | 21,344 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $974,683 | 21,272 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,146,859 | 23,671 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $944,374 | 24,036 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $730,089 | 19,834 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $839,355 | 18,415 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $563,441 | 15,765 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $405,239 | 20,477 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $437,218 | 18,797 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $247,219 | 11,897 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $295,284 | 13,639 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $300,399 | 12,745 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $237,026 | 20,104 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||